Pharmaceutical and health regulatory law: Our lawyers advise on all regulatory matters affecting companies’ day-to-day activities, from regulatory issues relating to setting up their activities, obtaining marketing authorizations, the establishing of prices and refunds by the public authorities, and all issues concerning manufacturing, promoting, commercializing and selling products, to representing and defending clients in litigation with the public authorities and all other type of proceedings.
Personal data protection: We audit, advise, represent and defend clients in administrative and legal proceedings on personal data protection, particularly relating to health data.
Intellectual property and unfair competition: We represent clients in patent, trademark and unfair competition litigation (including infringement or revocation IP proceedings), as well as advising on IP, know-how and data protection, and negotiating commercial transactions involving IP rights and know-how, such as licensing and codevelopment agreements.
Tax: Our lawyers provide ongoing tax advice to some of the most important companies in this field, as well as advising on tax planning and representing and defending clients in tax litigation proceedings.
Corporate & commercial: Our lawyers design and implement corporate transactions (joint ventures, mergers and acquisitions), negotiating contracts for all types of commercial transactions (including transactions to buy products and transfer dossiers; agreements on clinical trials; and manufacturing, distribution and storage contracts), and defend and represent clients in related disputes and litigation.
Industrial relations: We advise on recruitment, labor disputes, and designing payment systems, such as stock options.
Product and tort liability litigation: We represent clients in disputes and litigation proceedings (administrative, civil and criminal proceedings) concerning product and tort liability.
Competition: We advise on antitrust law, having specific knowledge of the sector’s issues, such as on parallel imports, marketing and promotion agreements, transferring IP rights, pricing, access to and disclosure of authorization dossiers, and merger control.
